Schizophrenia, Depression, AnxietyPain
Neuropathic-Chung, CCI, Visceral-Endometriosis, Bladder, Chemotherapy-induced pain, Central PainOncology
Syngenic Melanoma, Xenograph, Pancreatic Cancer, Glioblastom
Dry eye disease, AMD
NASH, DiabetesSafety & Toxicology
Mouse, rat, canine, pig, NHP, ADME PK
Drug Development Support
Naason Science can help to take early stage candidate technologies and move them forward – swiftly and precisely. Utilizing its inherent drug development experience, scientific expertise and technical capabilities Naason Science changes how drug development collaboration is done.
Production of Customized Animal Models
Naason Science provides a cutting-edge research environment with which to develop custom models
in one place and in all species. All of the state-of-the-art research tools to create and expand customized animal models are available.
Recources and Facilities
Rodents, large animals, non-human primates are available.
List of Naason Science Technologies and Capabilities >>>
Safety and Toxicity Studies
Rodents and larger species (rabbits, pigs, dogs and NHP) all aspects of non-clinical safety and toxicity can be studied.
Specialized in Gene Therapy
The Naason scientists and staff are highly specialized in the administration of gene therapies and the associated techniques. Naason facilities are geared toward the genetic creation of models as well as the handling, storage and administration of biologics and gene therapies.
Cutting-edge facilities and instrumentation
Expertise in supporting preclinical development
Infrastructure to establish new disease models and innovative technologies
Know-how in drug development and outsourcing market analysis
Expertise in drug discovery and development
Expertise in developing new testing batteries
Naason Science CRO (Contract Research Organization) - Where the next generation of preclinical research begins!Faster, better decisions - Based on knowledge of drug discovery and outsourcing experience, building the best integrated global preclinical services with an emphasis on innovation, reliability and commitment. Naason´s various preclinical modelling platforms are customized to suite the needs of drug developers. The platforms can accommodate all drug delivery routes as well as preclinical proof-of-concept for medical devices. From in vitro systems to large and small animal in vivo models Naason Science provides a tool box of state-of-the-art technologies the allow for rapid and effective testing of preclinical drug candidates. The Naason process starts from an in-depth knowledge of the demands of global pharmaceutical development. It involves combining superior knowledge of biological systems and system dynamics with the latest preclinical disease models, highlighting the comparative and translatable aspects and using this data to highlight the way forward for a particular drug or a drug development platform. The data generated from our preclinical modelling platforms is designed to provide pertinent insight and better translatability in order to allow for easier decisions made faster. Faster decision making allows a reduction in the cost of research and development. Naason Science provides the tools to study neurology, oncology, cardiovascular and metabolic therapies in a way that allows faster and better decisions. Let us show you !
150+ Years of Cumulative CRO and Preclinical Drug Development Experience
located in two world class cutting-edge centers of Osong Bio-medical Science Complex in Osong and DGMIF in Daegu, South Korea.
Copyright © Naason Science Inc 2019. All rights reserved.